Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis ; volume:22 ; number:1 ; day:20 ; month:3 ; year:2021 ; pages:1-5 ; date:12.2021
BMC nephrology ; 22, Heft 1 (20.3.2021), 1-5, 12.2021
- Urheber
-
Ichii, Mitsuru
Mori, Katsuhito
Miyaoka, Daichi
Sonoda, Mika
Tsujimoto, Yoshihiro
Nakatani, Shinya
Shoji, Tetsuo
Emoto, Masanori
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-021-02304-2
- URN
-
urn:nbn:de:101:1-2021050617313263023594
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ichii, Mitsuru
- Mori, Katsuhito
- Miyaoka, Daichi
- Sonoda, Mika
- Tsujimoto, Yoshihiro
- Nakatani, Shinya
- Shoji, Tetsuo
- Emoto, Masanori
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pancreatic Thyrotropin Releasing Hormone and Mechanism of Insulin Secretion
Thyrotropin
Thyrotropin-Ampullen
Hemodialysis patients’ preferences for the management of anemia
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Thyrotropin Receptor Blocking Antibodies
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Der überschiessende Thyrotropin-Releasing-Hormon-Test
Cardiovascular pharmacology of thyrotropin releasing hormone
Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume
Pancreatic Thyrotropin Releasing Hormone and Mechanism of Insulin Secretion
Thyrotropin
Thyrotropin-Ampullen
Hemodialysis patients’ preferences for the management of anemia
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Thyrotropin Receptor Blocking Antibodies
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Der überschiessende Thyrotropin-Releasing-Hormon-Test
Cardiovascular pharmacology of thyrotropin releasing hormone
Management of iron deficiency anemia in hemodialysis patients based on mean corpuscular volume
Pancreatic Thyrotropin Releasing Hormone and Mechanism of Insulin Secretion
Thyrotropin
Thyrotropin-Ampullen
Hemodialysis patients’ preferences for the management of anemia
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Thyrotropin Receptor Blocking Antibodies
Trends in anemia management in US hemodialysis patients 2004–2010
Optimizing anemia management using artificial intelligence for patients undergoing hemodialysis
Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
Der überschiessende Thyrotropin-Releasing-Hormon-Test
Cardiovascular pharmacology of thyrotropin releasing hormone